CV disorder risks extend beyond COX-2-selectivity of NSAIDs

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1170, 2007-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased COX-2 selectivity of NSAIDs appears to be associated with increased cardiovascular (CV) risks

By  

Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

NSAID-related CV risks not defined by COX-2 selectivity alone

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Selective COX-2 inhibitors vs NSAIDs discussed

By  

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

COX-2 Selectivity and Inflammatory Processes.

By  

Current Medicinal Chemistry, Vol. 7, Iss. 11, 2000-11 ,pp. : 1145-1161

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 use grows despite little added benefit over NSAIDs

By  

Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite